Using a measure of the hormone N-terminal brain natriuretic peptide (BNP) to guide therapy for older patients with heart failure did not improve overall clinical or quality of life outcomes compared ...

First results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) show that testing for brain natriuretic peptide (BNP) when evaluating congestive heart failure (CHF) patients ...

Brain natriuretic peptides (BNPs) are released from cardiac myocytes in times of ventricular wall stress; their levels correlate with the severity of heart failure. The prognostic value of BNP levels ...

B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.

B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic review ...